Sunday, September 21, 2014

Novadaq names Robert White to its board

Novadaq names Robert White to its board

September 2, 2014 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has appointed Robert White to its board. Mr. White is a medical technology industry veteran with over 25 years of high-level experience gained through numerous leadership positions with Medtronic, Instromedix-LifeWatch, ALARIS Medical Systems, Eli Lilly and General Electric. He was most recently president and CEO of TYRX, a closely-held company […]

Novadaq Q2 revenue jumps on direct sales

Novadaq Q2 revenue jumps on direct sales

August 5, 2014 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) posted a 38% gain in second quarter revenue to $11.2-million. Novadaq’s strategy of investing in a direct sales team resulted in $5.1-million in PINPOINT and LUNA sales, compared with $1.2-million in the second quarter last year. “The second quarter marks a milestone for us, as approximately half of our revenues […]

Three BT-featured CEOs sweep EY award finalist selections

Three BT-featured CEOs sweep EY award finalist selections

July 7, 2014 by · Leave a Comment 

Tweet All three finalists for the EY 2014 Ontario Entrepreneur of the Year award in the health sciences category have been featured in the past on BioTuesdays.com. They are Anthony Giovinazzo of Cynapsus Therapeutics (OTCQX:CYNAF; TSX-V:CTH), Tom Reeves of closely held Interface Biologics and Dr. Arun Menawat of Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ). The Ontario winners will be announced […]

Analyst highlights Novadaq, Cipher on BNN

Analyst highlights Novadaq, Cipher on BNN

July 7, 2014 by · Leave a Comment 

Tweet Douglas Loe, a health care and biotech analyst with Euro Pacific Canada, discussed the state of the sector today in an interview with BNN’s Pamela Richie. Mr. Loe’s buy recommendations include Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) and Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND). The interview can be accessed here.

RBC upgrades Novadaq to outperform

RBC upgrades Novadaq to outperform

May 8, 2014 by · Leave a Comment 

Tweet RBC Capital Markets has upgraded Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) to “outperform” from “sector perform,” holding its price target at $18. The stock closed at $14.06 on Wednesday. “First quarter earnings were largely in-line but concerns related to a potential partner transition and associated product performance appear to have caused some concern,” writes analyst Douglas […]

Novadaq Q1 revenue climbs 41%

Novadaq Q1 revenue climbs 41%

May 7, 2014 by · Leave a Comment 

Tweet First quarter revenue for Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) rose 41% to $10.3-million from $7.3-million a year ago. The company’s strategy of investing in a direct sales team resulted in sales of PINPOINT and LUNA products reaching $4.6-million, compared with $200,000 in the first quarter last year $3.3-million in the final quarter of 2013. First […]

Novadaq to acquire Aimago S.A.

Novadaq to acquire Aimago S.A.

April 24, 2014 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has agreed to acquire all outstanding shares of Aimago S.A., a closely held medical imaging company, founded in 2008 as a spin off from Ecole Polytechnique Federale de Lausanne, a Swiss-based academic and research institution. Aimago’s lead product, the EasyLDI Perfusion Camera, incorporates patented, high-speed, full field laser Doppler technology. […]

In conversation with Tony Pullen

In conversation with Tony Pullen

April 1, 2014 by · Leave a Comment 

Tweet Tony Pullen is one of the deans of Canadian capital markets. His career in biotech traces its roots to 1985 as an advisor to Cangene, which merged with Emergent BioSolutions (NYSE:EBS) in February. He also was instrumental in raising the initial capital for MDS Health Ventures, which went on to become MDS Capital Corp., […]

Novadaq revenue up 57% in Q4

Novadaq revenue up 57% in Q4

February 6, 2014 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has reported fourth quarter revenue of $10.7-million, a 57% year-over-year gain, bringing revenue for all of 2013 to $35-million, an increase of 52%, compared with 2012. Growth was driven by increases in the number of patients treated using the company’s fluorescence imaging technologies, and increases in capital sales of its […]

Novadaq preliminary Q4 revenue $10.7-million

Novadaq preliminary Q4 revenue $10.7-million

January 14, 2014 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has releasing preliminary unaudited revenue for the fourth quarter of 2013 of approximately $10.7-million, bringing expected full-year 2013 revenue to approximately $35-million. The preliminary unaudited quarterly numbers have not gone through review and audit procedures by the company’s external auditors and may differ from actual revenues. Complete financial results and […]

Next Page »

Email Newsletters with Constant Contact
Google+